Laura Gaetano (L Gaetano)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Disease Activity

Subarachnoid Hemorrhage

Diffusion Weighted Imaging

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, Corrado Bernasconi, Ulrike Bonati, Colm Elliott, Niels Hagenbuch, Stefano Magon, Douglas L Arnold, Anthony Traboulsee
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (6) (2023)
Marco Ganzetti, Jennifer S Graves, Sven P Holm, Frank Dondelinger, Luciana Midaglia, Laura Gaetano, Licinio Craveiro, Florian Lipsmeier, Corrado A Bernasconi, Xavier Montalban, Stephen L Hauser, Michael Lindemann
Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis. Journal of neurology (2022)
Anitha Priya Krishnan, Zhuang Song, David Clayton, Laura Gaetano, Xiaoming Jia, Alex de Crespigny, Thomas Bengtsson, Richard A D Carano
Joint MRI T1 Unenhancing and Contrast-enhancing Multiple Sclerosis Lesion Segmentation with Deep Learning in OPERA Trials. Radiology 302 (3) (2021)
Tobias Derfuss, Jaume Sastre-Garriga, X Montalban, M Rodegher, J Wuerfel, Laura Gaetano, D Tomic, A Azmon, Christian Wolf, Ludwig Kappos
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 6 (1) (2020)
Laura Gaetano, Baldur Magnusson, Petya Kindalova, Davorka Tomic, Diego Silva, Anna Altermatt, Stefano Magon, Nicole Müller-Lenke, Ernst-Wilhelm Radue, David Leppert, Ludwig Kappos, Jens Wuerfel, Dieter A Häring, Till Sprenger
White matter lesion location correlates with disability in relapsing multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical 6 (1) (2020)